Search Results for: ABIO
Selecta Biosciences and Sarepta Therapeutics have announced that they had entered into a research license and option agreement.
Published:
Gossamer Bio shares dived on Tuesday after the company announced midstage results from its asthma and chronic rhinosinusitis studies.
Published:
Applera Corporation had an SEC Filing today saying its Board of Directors has authorized management to pursue a possible separation of the Celera Group (NYSE:CRA) from Applera. The completion of this...
Published:
Last Updated:
Mustang Bio shares more than doubled on Thursday after the company announced a breakthrough that cured eight infants dealing with the "Bubble Boy" immune disorder.
Published:
Last Updated:
Neurocrine Biosciences made waves in the market on Thursday morning after it announced positive results in a Phase 3 trial.
Published:
Neurocrine Bio shares dipped on Wednesday after the company announced that its midstage Tourette syndrome study did not live up to expectations.
Published:
Last Updated:
Bio Blast Pharma was blowing away all the other bulls in Wednesday’s session, with its stock up over 150% on positive clinical results.
Published:
Last Updated:
vTv Therapeutics watched its shares make a massive gain early on Thursday after the firm announced an exclusive licensing agreement with Newsoara Biopharma.
Published:
Last Updated:
This article is sponsored by Corporate Citizen Project. Investment management giant BlackRock voted in 2021 in support of 149 U.S. shareholder proposals related to environmental, social, and...
Published:
Source: courtesy Making Change at Walmart and UFCWWall Street considered almost all the news from Wal-Mart Stores Inc.’s (NYSE: WMT) earings as bad. U.S. comp sales declined 1.4% in the 13-week...
Published:
Stealth Bio shares were absolutely crushed on Friday after the firm announced results from its late-stage study in patients with primary mitochondrial myopathy (PMM). Specifically, the top-line...
Published:
Bluebird Bio shares have made a steady gain over the course of the year and now the firm is looking to cash in on this growth.
Published:
Last Updated:
Enochian Biosciences shares more than doubled to start out the week after the company received a critical update from the FDA regarding its HIV treatment.
Published:
Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way that management and the board of directors has handled it has been clumsy.
Published:
Highlighted stocks include AbbVie and Eli Lilly.
Published: